150 related articles for article (PubMed ID: 33535682)
1. Val16A SOD2 Polymorphism Promotes Epithelial-Mesenchymal Transition Antagonized by Muscadine Grape Skin Extract in Prostate Cancer Cells.
Sweeney JD; Debeljak M; Riel S; Millena AC; Eshleman JR; Paller CJ; Odero-Marah V
Antioxidants (Basel); 2021 Feb; 10(2):. PubMed ID: 33535682
[TBL] [Abstract][Full Text] [Related]
2. Muscadine grape skin extract reverts snail-mediated epithelial mesenchymal transition via superoxide species in human prostate cancer cells.
Burton LJ; Barnett P; Smith B; Arnold RS; Hudson T; Kundu K; Murthy N; Odero-Marah VA
BMC Complement Altern Med; 2014 Mar; 14():97. PubMed ID: 24617993
[TBL] [Abstract][Full Text] [Related]
3. Muscadine grape skin extract can antagonize Snail-cathepsin L-mediated invasion, migration and osteoclastogenesis in prostate and breast cancer cells.
Burton LJ; Smith BA; Smith BN; Loyd Q; Nagappan P; McKeithen D; Wilder CL; Platt MO; Hudson T; Odero-Marah VA
Carcinogenesis; 2015 Sep; 36(9):1019-27. PubMed ID: 26069256
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial SOD2 regulates epithelial-mesenchymal transition and cell populations defined by differential CD44 expression.
Kinugasa H; Whelan KA; Tanaka K; Natsuizaka M; Long A; Guo A; Chang S; Kagawa S; Srinivasan S; Guha M; Yamamoto K; St Clair DK; Avadhani NG; Diehl JA; Nakagawa H
Oncogene; 2015 Oct; 34(41):5229-39. PubMed ID: 25659582
[TBL] [Abstract][Full Text] [Related]
5. Muscadine grape skin extract inhibits prostate cancer cells by inducing cell-cycle arrest, and decreasing migration through heat shock protein 40.
Ignacio DN; Mason KD; Hackett-Morton EC; Albanese C; Ringer L; Wagner WD; Wang PC; Carducci MA; Kachhap SK; Paller CJ; Mendonca J; Li-Ying Chan L; Lin B; Hartle DK; Green JE; Brown CA; Hudson TS
Heliyon; 2019 Jan; 5(1):e01128. PubMed ID: 30705983
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of prostate cancer growth by muscadine grape skin extract and resveratrol through distinct mechanisms.
Hudson TS; Hartle DK; Hursting SD; Nunez NP; Wang TT; Young HA; Arany P; Green JE
Cancer Res; 2007 Sep; 67(17):8396-405. PubMed ID: 17804756
[TBL] [Abstract][Full Text] [Related]
7. Muscadine Grape Skin Extract Induces an Unfolded Protein Response-Mediated Autophagy in Prostate Cancer Cells: A TMT-Based Quantitative Proteomic Analysis.
Burton LJ; Rivera M; Hawsawi O; Zou J; Hudson T; Wang G; Zhang Q; Cubano L; Boukli N; Odero-Marah V
PLoS One; 2016; 11(10):e0164115. PubMed ID: 27755556
[TBL] [Abstract][Full Text] [Related]
8. CD147 promotes epithelial-mesenchymal transition of prostate cancer cells via the Wnt/β-catenin pathway.
Fang F; Li Q; Wu M; Nie C; Xu H; Wang L
Exp Ther Med; 2020 Oct; 20(4):3154-3160. PubMed ID: 32855684
[TBL] [Abstract][Full Text] [Related]
9. The SOD2 Val/Val genotype enhances the risk of nonsmall cell lung carcinoma by p53 and XRCC1 polymorphisms.
Liu G; Zhou W; Park S; Wang LI; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC
Cancer; 2004 Dec; 101(12):2802-8. PubMed ID: 15534883
[TBL] [Abstract][Full Text] [Related]
10. Analytical Validation of
Debeljak M; Riel S; Lin MT; Eshleman JR; Paller CJ
Methods Protoc; 2022 Dec; 6(1):. PubMed ID: 36648953
[TBL] [Abstract][Full Text] [Related]
11. High mobility group A2 (HMGA2) promotes EMT via MAPK pathway in prostate cancer.
Hawsawi O; Henderson V; Burton LJ; Dougan J; Nagappan P; Odero-Marah V
Biochem Biophys Res Commun; 2018 Sep; 504(1):196-202. PubMed ID: 30177390
[TBL] [Abstract][Full Text] [Related]
12. Sonic hedgehog and androgen signaling in tumor and stromal compartments drives epithelial-mesenchymal transition in prostate cancer.
Yamamichi F; Shigemura K; Behnsawy HM; Meligy FY; Huang WC; Li X; Yamanaka K; Hanioka K; Miyake H; Tanaka K; Kawabata M; Shirakawa T; Fujisawa M
Scand J Urol; 2014 Dec; 48(6):523-32. PubMed ID: 25356787
[TBL] [Abstract][Full Text] [Related]
13. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
14. Juglone suppresses epithelial-mesenchymal transition in prostate cancer cells via the protein kinase B/glycogen synthase kinase-3β/Snail signaling pathway.
Fang F; Chen S; Ma J; Cui J; Li Q; Meng G; Wang L
Oncol Lett; 2018 Aug; 16(2):2579-2584. PubMed ID: 30013652
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial Superoxide Dismutase Has a Protumorigenic Role in Ovarian Clear Cell Carcinoma.
Hemachandra LP; Shin DH; Dier U; Iuliano JN; Engelberth SA; Uusitalo LM; Murphy SK; Hempel N
Cancer Res; 2015 Nov; 75(22):4973-84. PubMed ID: 26359457
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
18. ETS1 induces transforming growth factor β signaling and promotes epithelial-to-mesenchymal transition in prostate cancer cells.
Rodgers JJ; McClure R; Epis MR; Cohen RJ; Leedman PJ; Harvey JM; ; Thomas MA; Bentel JM
J Cell Biochem; 2019 Jan; 120(1):848-860. PubMed ID: 30161276
[TBL] [Abstract][Full Text] [Related]
19. SOD2 gene polymorphism and response of oxidative stress parameters in young wrestlers to a three-month training.
Jówko E; Gierczuk D; Cieśliński I; Kotowska J
Free Radic Res; 2017 May; 51(5):506-516. PubMed ID: 28482710
[TBL] [Abstract][Full Text] [Related]
20. Targeting the SPOCK1-snail/slug axis-mediated epithelial-to-mesenchymal transition by apigenin contributes to repression of prostate cancer metastasis.
Chien MH; Lin YW; Wen YC; Yang YC; Hsiao M; Chang JL; Huang HC; Lee WJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):246. PubMed ID: 31182131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
